Shandong Weigao Group repurchases shares on Hong Kong Exchange

Shandong Weigao Group Medical Polymer Company Limited (HKEX:1066) announced that it repurchased 99,600 of its ordinary shares on the Hong Kong Exchange on July 7, 2025. The shares were bought back at a price range of HKD 5.97 to HKD 6. The total amount paid for the repurchase was HKD 596,000. Following this transaction, the company’s number of issued shares (excluding treasury shares) stands at 4,514,020,324, with treasury shares numbering 8,312,000. The repurchase was carried out in accordance with the Main Board Rules of the Hong Kong Stock Exchange. The company has a mandate to repurchase up to 451,560,392 shares, authorized by a resolution passed on May 27, 2025. The moratorium period for any issue of new shares or sale of treasury shares after the repurchase ends on August 7, 2025.